Inventor · disambiguated record
Michael Tovey
Also filed as: TOVEY MICHAEL · TOVEY MICHAEL G · TOVEY MICHAEL GERARD
20 granted patents·27 pending applications·369 citations·filing 1975–2022
95Inventor score
Top patents by PatentIndex Score
47 records- 0189US7465451B2Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferonMEDAREX INC·Filed 2006·Granted Dec 16, 2008·11 cites·16 claims
- 0289US7179465B2Monoclonal antibodies against the interferon receptor, with neutralizing activity against type 1 interferonMEDAREX INC·Filed 2004·Granted Feb 20, 2007·27 cites·15 claims
- 0387US6207145B1Therapeutic applications of high dose interferonPHARMA PACIFIC PTY LTD·Filed 1997·Granted Mar 27, 2001·82 cites·15 claims
- 0486US5919453AMonoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferonEUROP BIOTECHNOLOGIE·Filed 1993·Granted Jul 6, 1999·50 cites·22 claims
- 0579US6787634B2Isolated peptide or polypeptide of the extracellular portion of the human interferon receptor (IFN-R).MEDISUP INT NV·Filed 1999·Granted Sep 7, 2004·37 cites·5 claims
- 0678US8759091B2Gene reporter assay, kit and cells with improved sensitivity and/or specificity for determining the level of an extracellular signalTOVEY MICHAEL G·Filed 2007·Granted Jun 24, 2014·4 cites·27 claims
- 0777US6475983B1Water-soluble polypeptides having a high affinity for α and β interferonsMEDISUP INTERNAT N V·Filed 1991·Granted Nov 5, 2002·46 cites·31 claims
- 0874US6660258B1Oromucosal cytokine compositions and uses thereofPHARMA PACIFIC PTY LTD·Filed 1998·Granted Dec 9, 2003·42 cites·66 claims
- 0973US6361769B1Stimulation of host defense mechanisms against viral challengesPHARMA PACIFIC PTY LTD·Filed 1997·Granted Mar 26, 2002·35 cites·19 claims
- 1072US9188580B2Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface proteinTOVEY MICHAEL G·Filed 2008·Granted Nov 17, 2015·3 cites·24 claims
- 1170US7470536B2Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface proteinNEUTEKBIO LTD·Filed 2003·Granted Dec 30, 2008·10 cites·55 claims
- 1263US2008226647A1Monoclonal Antibodies Against The Interferon Receptor, With Neutralizing Activity Against Type I InterferonMEDAREX INC·Filed 2008·Application pending·0 cites
- 1360US10271539B2Assay-ready frozen cell and method for minimizing variability in the performance thereofLE CENTRE NATIONALE DE LA RECHERCHE SCIENT CNRS·Filed 2014·Granted Apr 30, 2019·0 cites·29 claims
- 1460US9969801B2Cell, method and kit for conducting an assay for neutralizing antibodiesTOVEY MICHAEL·Filed 2009·Granted May 15, 2018·2 cites·27 claims
- 1556US7244818B2Interferon alpha responsive proteinPHARMA PACIFIC PTY LTD·Filed 2000·Granted Jul 17, 2007·3 cites·2 claims
- 1656US2025270518A1Novel luciferases with improved propertiesSVAR LIFE SCIENCE AB·Filed 2022·Application pending·0 cites
- 1753US2009111178A1Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface proteinLE CT NATIONALE DE LA RECH SCI·Filed 2007·Application pending·0 cites
- 1852US2006275298A1Antagonist of Th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseasesPHARMA PACIFIC PTY LTD·Filed 2006·Application pending·0 cites
- 1951US2005112108A1Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. Use of said regulator as a therapeutic or diagnostic agentFiled 2003·Application pending·0 cites
- 2050US11280790B2System and products for improved quantification of ADCC activitySVAR LIFE SCIENCE AB·Filed 2017·Granted Mar 22, 2022·0 cites·17 claims
- 2150US2003108519A1Therapeutic applications of high dose in terferonPHARMA PACIFIC PTY LTD·Filed 2002·Application pending·0 cites
- 2250US2025341527A1Novel system for the detection and quantification of anti-aav neutralizing antibodiesSVAR LIFE SCIENCE AB·Filed 2022·Application pending·0 cites
- 2348US2007042963A1Therapeutic peptidesMEDAREX INC·Filed 2006·Application pending·0 cites
- 2447US8426123B2Method for conducting an assay for neutralizing antibodiesTOVEY MICHAEL G·Filed 2008·Granted Apr 23, 2013·0 cites·25 claims
- 2546US12025620B2System and products for improved quantification of ADCC and ADCP activitySVAR LIFE SCIENCE AB·Filed 2019·Granted Jul 2, 2024·0 cites·17 claims
- 2645US5997858AStimulation of host defense mechanisms against tumorsPHARMA PACIFIC PTY LTD·Filed 1997·Granted Dec 7, 1999·14 cites·16 claims
- 2745US2003147889A1Antagonist of th-1 immunerresponse inducing cytokine for the treatment of autoimmune diseasesFiled 2001·Application pending·0 cites
- 2842US2005129657A1Interferon-alpha induced genePHARMA PACIFIC PTY LTD·Filed 2004·Application pending·0 cites
- 2942US2007117145A1Interferon-alpha induced genesPHARMA PACIFIC PTY LTD·Filed 2006·Application pending·0 cites
- 3041US12359195B2Secreted reporter-peptides for optimizing cell-based assays for analysis on immuno-assay platformsSVAR LIFE SCIENCE AB·Filed 2018·Granted Jul 15, 2025·0 cites·13 claims
- 3141US3951740AManufacture of interferonANVAR·Filed 1975·Granted Apr 20, 1976·3 cites·9 claims
- 3241US2006275258A1Interferon-alpha induced genePHARMA PACIFIC PTY LTD·Filed 2006·Application pending·0 cites
- 3341US2005265967A1Interferon-alpha induced genePHARMA PACIFIC PTY LTD·Filed 2003·Application pending·0 cites
- 3440US2008193412A1Method of Enhancing the Immune Response to a VaccinePHARMA PACIFIC PTY LTD·Filed 2005·Application pending·0 cites
- 3540US2006141580A1Interferon-alpha induced genePHARMA PACIFIC PTY LTD·Filed 2006·Application pending·0 cites
- 3640US2006099174A1Interferon-alpha induced genesPHARMA PACIFIC PTY LTD·Filed 2006·Application pending·0 cites
- 3739US2021293784A1System for the adaptation of cell-based assays for analysis on automated immuno-assay platformsSVAR LIFE SCIENCE AB·Filed 2018·Application pending·0 cites
- 3838US2004067888A1Therapeutic peptidesFiled 2001·Application pending·0 cites
- 3935US2009081162A1Method for downregulating an immune reactionTOVEY MICHAEL·Filed 2005·Application pending·0 cites
- 4034US2007226815A1Interferon-alpha induced genePHARMA PACIFIC PTY LTD·Filed 2006·Application pending·0 cites
- 4134US2004170961A1Interferon-alpha induced genePHARMA PACIFIC PTY LTD·Filed 2003·Application pending·0 cites
- 4232US2004043402A1Interferon-alpha induced geneFiled 2001·Application pending·0 cites
- 4331US2003176341A1Interferon-alpha induced geneFiled 2001·Application pending·0 cites
- 4431US2003194732A1Interferon-alpha induced geneFiled 2001·Application pending·0 cites
- 4530US2003157506A1Interferon-alpha induced genesFiled 2001·Application pending·0 cites
- 4630US2003186321A1Interferon-alpha induced genesFiled 2001·Application pending·0 cites
- 4726US2004175803A1Interferon-alpha induced geneFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Tovey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →